Urologix announces milestone in Prositiva RF therapy licensing agreement


Urologix (U:GX) announced that it has reached an important milestone in its licensing agreement with Medtronic (MDT) for the Prostiva RF Therapy System. In accordance with the terms of the agreement, Urologix has become the licensed manufacturer for the Prostiva RF Therapy System, taking manufacturing and regulatory responsibility for the product line. This milestone represents an important step in the integration of the Prostiva product line into the broader Urologix organization and will allow the company to work directly with our manufacturing partners to ensure continued focus on both quality and efficiency going forward. In addition, achieving this milestone enables the company to market and sell all Prostiva RF Therapy products distributed throughout the United States under the Urologix brand name.

View Comments (1)